Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Growth Hormone for Muscle Atrophy in ACL Tears
NCT02420353Phase 2Completed
- Sponsor
- University of Michigan
- Start
- May 2015
- Primary completion
- Oct 2018
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of somatropin in anterior cruciate ligament injury, sponsored by University of Michigan. Started May 2015; status: completed.
02
Drugs
somatropin
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT02420353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02420353.